Study of a new eye implant for stubborn glaucoma
Part of Eyes & vision clinical trials.
This study tests a new device to lower eye pressure in people with hard-to-control glaucoma. It is for those who have not had success with other treatments and have open-angle or traumatic glaucoma with high eye pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 22 and 85 years old.
- Your glaucoma is hard to control—either eye drops don't work well enough, you've had a glaucoma surgery or laser that didn't help, or you have scarring that makes standard surgery risky.
- You have open-angle or traumatic glaucoma (not other types like angle-closure or pigmentary).
- Your eye pressure is between 25 and 45 mmHg while on maximum eye drops.
- You have enough healthy white part of the eye at the top to place the implant.
- You do not have certain other eye conditions (like active infection, severe corneal problems, or prior eye surgery within 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a tiny implant called MINIject S+ to lower eye pressure in people with open angle glaucoma that isn't well controlled with eye drops. It may be done alone or with cataract surgery.
This trial is testing a small device called the PRESERFLO MicroShunt to lower eye pressure in people with open-angle glaucoma. It may be an option if your eye pressure stays high even with maximum eye drops.
This study compares two types of drainage implants (Baerveldt and Paul) to see which one works better at lowering eye pressure in people with glaucoma. If your glaucoma is not controlled with eye drops or other treatments, this trial may help find a more effective option.
This trial is testing a new device (VividFlo) to lower eye pressure in people with stubborn glaucoma that hasn't been controlled by other treatments. It aims to see if the device works and is safe for creating a new drainage route in the eye.
This trial compares two different tiny drainage devices (a gel stent and a microshunt) for lowering eye pressure in people with certain types of glaucoma that are not well controlled with medications. The goal is to see which device works better and is safer.
This trial tests a surgery that combines cataract removal with a new technique to lower eye pressure in people who have both primary open-angle glaucoma and cataracts. It aims to see if this combined surgery is safe and effective.
Hear when a new Refractory Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.